Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix

ClinicalTrials.gov ID: NCT00006482

Public ClinicalTrials.gov record NCT00006482. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation Of Gemcitabine And Cisplatin In Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix

Study identification

NCT ID
NCT00006482
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • cisplatin Drug
  • gemcitabine hydrochloride Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2000
Primary completion
Mar 31, 2006
Completion
Not listed
Last update posted
Apr 10, 2013

Started 2000

United States locations

U.S. sites
33
U.S. states
18
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Rational Therapeutics Inc. Long Beach California 90807
Community Hospital of Los Gatos Los Gatos California 95032
Chao Family Comprehensive Cancer Center Orange California 92868
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5000
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612
University of Illinois College of Medicine at Peoria Peoria Illinois 61603
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky 40536-0084
Tufts University School of Medicine Boston Massachusetts 02111
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Cooper Hospital/University Medical Center Camden New Jersey 08103
Cancer Center of Albany Medical Center Albany New York 12208
State University of New York Health Science Center at Brooklyn Brooklyn New York 11203
Roswell Park Cancer Institute Buffalo New York 14263-0001
Schneider Children's Hospital at North Shore Manhasset New York 11030
Memorial Sloan-Kettering Cancer Center New York New York 10021
Lineberger Comprehensive Cancer Center, UNC Chapel Hill North Carolina 27599-7295
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1082
Barrett Cancer Center, The University Hospital Cincinnati Ohio 45267-0502
Ireland Cancer Center Cleveland Ohio 44106-5065
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190
Abington Memorial Hospital Abington Pennsylvania 19001
Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104-4283
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Simmons Cancer Center - Dallas Dallas Texas 75235-9154
Cancer Center at the University of Virginia Charlottesville Virginia 22908
Tacoma General Hospital Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006482, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006482 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →